IMCD N.V.

IMCD N.V.

IMDZF
IMCD N.V.US flagOther OTC
108.80
USD
- -
- -
6.42BMarket Cap
IMCD N.V.
IMDZF
(Other OTC)

Recent

price

108.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
43.02
55.83
61.67
54.08
29.64
32.67
36.38
45.38
51.26
51.63
60.33
80.83
78.05
- -
80.93
Revenue per Share
-1.51
-0.89
-0.27
0.79
1.2
1.39
1.47
1.91
2.06
2.23
3.64
5.5
5.13
- -
3.68
Basic EPS, GAAP
0.73
1.53
0.1
1.29
1.48
1.79
1.93
1.94
2.98
3.98
3.12
4.88
6.72
- -
5.11
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.19
0.44
0.55
0.62
0.8
0.88
1.02
1.62
2.37
- -
2.15
Dividend per Share
-1.51
-2.4
-2.67
-1.02
0.52
1.46
2.38
3.63
4.87
6.03
8.29
12.12
13.59
- -
17.15
Book Value per Share
-31.74
-33.68
-36.9
-5.35
-4.91
-3.53
-4.19
-4.83
-5.24
-5.48
-6.09
-4.7
-9.38
- -
-10.42
Tangible Book Value per Share
20
20
20
25
52
52
52
52
52
54
57
57
57
- -
59
Basic Weighted Avg Shares
860
1,117
1,233
1,358
1,530
1,714
1,907
2,379
2,690
2,775
3,435
4,601
4,443
4,728
4,779
Sales/Revenue/Turnover
4.33
6.25
5.95
6.06
6.51
6.72
6.56
6.88
6.71
7.02
8.89
10.03
9.65
8.99
7.77
Operating Margin (%)
26
19
22
23
38
42
39
43
66
73
93
111
114
137
143
Depreciation Expense
-30
-18
-5
20
62
73
77
100
108
120
207
313
292
278
218
Net Income, GAAP
- -
- -
165.84
19.67
20.57
23.01
29.75
28.12
27.68
27.01
26.99
28.19
27.5
26.78
25.29
Effective Tax Rate (%)
-3.52
-1.6
-0.44
1.47
4.04
4.26
4.05
4.21
4.02
4.33
6.03
6.8
6.58
5.89
4.55
Profit Margin (%)
113
1
147
215
199
234
192
270
266
298
339
656
729
1,023
760
Working Capital
679
605
820
302
408
383
367
481
566
390
392
913
1,168
1,368
1,365
LT Debt
-28
-50
-67
531
654
722
729
786
867
1,252
1,461
1,673
1,726
2,215
2,042
Total Equity
- -
- -
-6.45
8.04
8.17
8.04
7.84
9.75
9.4
8.75
12.11
14.38
10.97
8.99
7.14
Return on Invested Capital (%)
- -
- -
-6.42
12.02
19.81
18.47
18.23
20.1
16.59
16.37
26.06
26.14
18.09
14.45
10.08
Return on Capital (%)
- -
- -
- -
- -
- -
141.27
76.66
63.45
48.42
41.43
52.05
53.87
39.94
32.81
22.49
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.89%
10.97%
-7.81%
Free Cash Flow
18.49%
12.53%
19.47%
Net Income, GAAP
16.29%
18.07%
-21.8%
Sales/Revenue/Turnover
12.61%
12.36%
1.08%
Total Cash Common Dividend
33.24%
24.39%
-0.49%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4,443
2024
- -
- -
- -
- -
4,728
2025
- -
- -
- -
- -
4,779

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5.13
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
3.68

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.37
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
2.15
Business
IMCD N.V. (IMDZF) is a global specialty chemicals and ingredients distributor that serves the pharmaceutical, food, advanced materials, coatings, personal care, and life science industries. The company provides a broad portfolio of products including active pharmaceutical ingredients, excipients, nutraceuticals, flavors, fragrances, polymers, resins, pigments, additives, surfactants, and emulsifiers; it offers value-added services such as formulation development, regulatory support, technical consulting, and supply chain optimization. Founded in 1998 and headquartered in Rotterdam, Netherlands, IMCD operates in over 60 countries across Europe, the Americas, Asia-Pacific, Middle East, and Africa, with a network of more than 50 offices and serving thousands of suppliers and customers worldwide. In recent developments, IMCD expanded its footprint through the 2024 acquisition of a leading Latin American distributor to strengthen its position in advanced materials and coatings segments; it also launched new digital platforms for enhanced customer ordering and inventory management in 2025, alongside strategic partnerships with key suppliers in sustainable ingredients for the food and pharma sectors. The company maintains a decentralized structure with regional business units tailored to local markets, targeting principally manufacturers and formulators in high-growth specialty sectors.